410 related articles for article (PubMed ID: 24633304)
1. Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression.
Mouw JK; Yui Y; Damiano L; Bainer RO; Lakins JN; Acerbi I; Ou G; Wijekoon AC; Levental KR; Gilbert PM; Hwang ES; Chen YY; Weaver VM
Nat Med; 2014 Apr; 20(4):360-7. PubMed ID: 24633304
[TBL] [Abstract][Full Text] [Related]
2. ECM stiffness paves the way for tumor cells.
Seewaldt V
Nat Med; 2014 Apr; 20(4):332-3. PubMed ID: 24710372
[No Abstract] [Full Text] [Related]
3. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
[TBL] [Abstract][Full Text] [Related]
4. Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland.
Jones CE; Hammer AM; Cho Y; Sizemore GM; Cukierman E; Yee LD; Ghadiali SN; Ostrowski MC; Leight JL
Neoplasia; 2019 Jan; 21(1):132-145. PubMed ID: 30550871
[TBL] [Abstract][Full Text] [Related]
5. Microenvironment: Tumour-promoting tissue mechanics.
Lokody I
Nat Rev Cancer; 2014 May; 14(5):296. PubMed ID: 24705651
[No Abstract] [Full Text] [Related]
6. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.
Korkaya H; Paulson A; Charafe-Jauffret E; Ginestier C; Brown M; Dutcher J; Clouthier SG; Wicha MS
PLoS Biol; 2009 Jun; 7(6):e1000121. PubMed ID: 19492080
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320.
Bronisz A; Godlewski J; Wallace JA; Merchant AS; Nowicki MO; Mathsyaraja H; Srinivasan R; Trimboli AJ; Martin CK; Li F; Yu L; Fernandez SA; Pécot T; Rosol TJ; Cory S; Hallett M; Park M; Piper MG; Marsh CB; Yee LD; Jimenez RE; Nuovo G; Lawler SE; Chiocca EA; Leone G; Ostrowski MC
Nat Cell Biol; 2011 Dec; 14(2):159-67. PubMed ID: 22179046
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
[TBL] [Abstract][Full Text] [Related]
11. MiR-638 serves as a tumor suppressor by targeting HOXA9 in glioma.
Zheng DH; Wang X; Lu LN; Chen DL; Chen JM; Lin FM; Xu XB
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7798-7806. PubMed ID: 30536324
[TBL] [Abstract][Full Text] [Related]
12. TGFβ-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion.
Dey N; Ghosh-Choudhury N; Kasinath BS; Choudhury GG
PLoS One; 2012; 7(8):e42316. PubMed ID: 22879939
[TBL] [Abstract][Full Text] [Related]
13. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
Ma L; Young J; Prabhala H; Pan E; Mestdagh P; Muth D; Teruya-Feldstein J; Reinhardt F; Onder TT; Valastyan S; Westermann F; Speleman F; Vandesompele J; Weinberg RA
Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells.
Chai C; Wu H; Wang B; Eisenstat DD; Leng RP
Carcinogenesis; 2018 Sep; 39(9):1185-1196. PubMed ID: 29985991
[TBL] [Abstract][Full Text] [Related]
15. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
[TBL] [Abstract][Full Text] [Related]
16. miR-18a increases insulin sensitivity by inhibiting
Zhou Y; Wu R; Su H; Li K; Chen C; Xie R
Aging (Albany NY); 2020 Dec; 13(1):1357-1368. PubMed ID: 33293478
[TBL] [Abstract][Full Text] [Related]
17. Quantitatively controlling expression of miR-17~92 determines colon tumor progression in a mouse tumor model.
Jiang H; Wang P; Wang Q; Wang B; Mu J; Zhuang X; Zhang L; Yan J; Miller D; Zhang HG
Am J Pathol; 2014 May; 184(5):1355-68. PubMed ID: 24681249
[TBL] [Abstract][Full Text] [Related]
18. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.
Iliopoulos D; Jaeger SA; Hirsch HA; Bulyk ML; Struhl K
Mol Cell; 2010 Aug; 39(4):493-506. PubMed ID: 20797623
[TBL] [Abstract][Full Text] [Related]
19. miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation.
Li B; Lu Y; Yu L; Han X; Wang H; Mao J; Shen J; Wang B; Tang J; Li C; Song B
Chem Biol Interact; 2017 Nov; 277():33-42. PubMed ID: 28844858
[TBL] [Abstract][Full Text] [Related]
20. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
